A CRISPR/Cas9-based genome editing system for Rhodococcus ruber TH

被引:56
|
作者
Liang, Youxiang [1 ,2 ]
Jiao, Song [1 ,2 ]
Wang, Miaomiao [1 ,2 ]
Yu, Huimin [1 ,2 ,3 ]
Shen, Zhongyao [1 ,2 ]
机构
[1] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Key Lab Ind Biocatalysis, Minist Educ, Beijing 100084, Peoples R China
[3] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China
基金
国家重点研发计划;
关键词
Rhodococcus; CRISPR/Cas9; Genome editing; Restriction-modification system; Recombinase; Acrylamide bio-production; NITRILE HYDRATASE; ESCHERICHIA-COLI; PLASMID TRANSFORMATION; EXPRESSION; VECTORS; BIOTRANSFORMATIONS; MUTAGENESIS; STRAIN; SACB;
D O I
10.1016/j.ymben.2019.10.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rhodococcus spp. are organic solvent-tolerant strains with strong adaptive abilities and diverse metabolic activities, and are therefore widely utilized in bioconversion, biosynthesis and bioremediation. However, due to the high GC-content of the genome (similar to 70%), together with low transformation and recombination efficiency, the efficient genome editing of Rhodococcus remains challenging. In this study, we report for the first time the successful establishment of a CRISPR/Cas9-based genome editing system for R. ruber. With a bypass of the restriction-modification system, the transformation efficiency of R. ruber was enhanced by 89-fold, making it feasible to obtain enough colonies for screening of mutants. By introducing a pair of bacteriophage recombinases, Che9-c60 and Che9c61, the editing efficiency was improved from 1% to 75%. A CRISPR/Cas9-mediated triple-plasmid recombineering system was developed with high efficiency of gene deletion, insertion and mutation. Finally, this new genome editing method was successfully applied to engineer R. ruber for the bioproduction of acrylamide. By deletion of a byproduct-related gene and in-situ subsititution of the natural nitrile hydratase gene with a stable mutant, an engineered strain R. ruber THY was obtained with reduced byproduct formation and enhanced catalytic stability. Compared with the use of wild-type R. ruber TH, utilization of R. ruber THY as biocatalyst increased the acrylamide concentration from 405 g/L to 500 g/L, reduced the byproduct concentration from 2.54 g/L to 0.5 g/L, and enhanced the number of times that cells could be recycled from 1 batch to 4 batches.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 50 条
  • [41] Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations
    Bhattacharya, Shreya
    Satpati, Priyadarshi
    ACS OMEGA, 2022, : 1817 - 1837
  • [42] Recent progress in CRISPR/Cas9-based genome editing for enhancing plant disease resistance
    Boubakri, Hatem
    GENE, 2023, 866
  • [43] CRISPR/Cas9-based genome editing to expedite the genetic improvement of palms: challenges and prospects
    Ramesh, Sv
    Rajesh, Mk
    Das, Alpana
    Hebbar, Kb
    FRONTIERS IN PLANT SCIENCE, 2024, 15
  • [44] Genetic advancements in obesity management and CRISPR–Cas9-based gene editing system
    Muthukumaran Jayachandran
    Zhaoliang Fei
    Shen Qu
    Molecular and Cellular Biochemistry, 2023, 478 : 491 - 501
  • [45] Nucleic acid nanostructure for delivery of CRISPR/Cas9-based gene editing system
    Tang, Wantao
    Liu, Jianbing
    Ding, Baoquan
    INTERDISCIPLINARY MEDICINE, 2023, 1 (01):
  • [46] CRISPR/Cas9-based gene editing for Rett syndrome therapy
    Croci, S.
    Beligni, G.
    Rossetti, A.
    Edo, A.
    Sorg, T.
    Manara, M.
    Lo Rizzo, C.
    Mencarelli, M. A.
    Canitano, R.
    Sica, M.
    Capitani, K.
    Conticello, S. G.
    Molinaro, F.
    Chiariello, M.
    Chillon, M.
    Ladewig, J.
    Herault, Y.
    Renieri, A.
    Meloni, I.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A141 - A141
  • [47] Unwinding the Role of FACT in Cas9-based Genome Editing
    Cosgrove, Brian D.
    Gersbach, Charles A.
    MOLECULAR CELL, 2020, 79 (03) : 365 - 367
  • [48] CRISPR/Cas9-based Gene Editing in Rice and Maize.
    Yang, Bing
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2017, 53 : S23 - S23
  • [49] Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis
    Zhao, Lan
    Huang, Jian
    Fan, Yunshan
    Li, Jun
    You, Tianming
    He, Shisheng
    Xiao, Guozhi
    Chen, Di
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (05) : 676 - 682
  • [50] CRISPR/Cas9-based gene activation and base editing in Populus
    Yao, Tao
    Yuan, Guoliang
    Lu, Haiwei
    Liu, Yang
    Zhang, Jin
    Tuskan, Gerald A.
    Muchero, Wellington
    Chen, Jin-Gui
    Yang, Xiaohan
    HORTICULTURE RESEARCH, 2023, 10 (06)